Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02240134 · ClinicalTrials.gov registry record · NA

Wood Stove Interventions and Child Respiratory Health

A NA study of Lower Tract Respiratory Infection, sponsored by University of Montana.

Completed
Registry status
NA
Development phase
523
Enrollment target
1
Study location

NCT02240134: Completed NA study of Lower Tract Respiratory Infection, sponsored by University of Montana.

NCT02240134 is a NA study of Lower Tract Respiratory Infection that has completed, run by University of Montana. The registered enrollment target is 523 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02240134, a NA study of Lower Tract Respiratory Infection, has completed, sponsored by University of Montana.

COMPLETED
Registry status
NA
Development phase
523 participants
Enrollment target
1
Study location

Study Summary

Acute lower respiratory tract infections (LRTIs) account for more than 27% of all hospitalizations among US children under five years of age, with recurrent LRTIs in children a recognized risk factor for asthma. Residential biomass combustion leads to elevated indoor levels of fine particulate matter (PM2.5) that often exceed current health-based air quality standards. PM2.5 exposure is associated with many adverse health outcomes, including a greater than three-fold increased risk of LRTIs. To date, exposure reduction strategies in wood stove homes have been either inconsistently effective or include factors that limit widespread dissemination and continued compliance in rural and economically disadvantaged populations. In this project, the investigators propose to test the efficacy of two intervention strategies for reducing indoor wood smoke PM2.5 exposures and children's risk of LRTI in three unique and underserved settings: (1) rural mountain valley communities in western Montana; (2) Navajo Nation communities; and (3) Alaska Native Villages. The investigators will conduct a three-arm randomized placebo-controlled post-only intervention trial in wood stove homes with children less than five years old. Education on best-burn practices and training on the use of simple instruments (i.e., stove thermometers and wood moisture meters) will be introduced as one intervention arm (Tx1). This intervention will be evaluated against an indoor air filtration unit arm (Tx2), as well as a placebo arm (Tx3, sham air filters). The primary outcome will be LRTI incidence among children under five years of age. To allow for detection of exposure and outcome differences within each of the three regions, a sample of 324 homes, or 108 within each study area will be equally assigned to each of the three intervention arms. The overall hypothesis is that a low-cost, educational intervention targeting indoor wood smoke PM2.5 exposures will be sustainable, and can reduce children's risk

Primary Outcome

The occurrence and duration of LRTI among children will be assessed using active surveillance within the home. Identification of LRTI episodes will occur through a three step process: (1) parent reporting of symptoms; (2) Community Coordinator collection of confirmatory and severity data; and (3) physician classification of case status based on data collected by the Community Coordinator, and when available, data collected from a clinic or hospital.

Interventions

  • BEHAVIORAL Education Intervention (Tx1)
  • DEVICE Air Filtration Unit Treatment (Tx2)
  • DEVICE Placebo Intervention (Tx3)

Study Locations (1)

Montana

  • University of Montana - Missoula

Trial Details

FieldValue
Enrollment Target 523 participants
Start Date 2014-11
Est. Completion 2020-03
Phase NA
University of Montana

24 total trials

What the finished NCT02240134 record still lists

NCT02240134 is an interventional study that assigns participants to a tested intervention. The registered 523 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (63% lower).

The record links to 1 condition, with Lower Tract Respiratory Infection appearing as the primary indexed condition, and to 3 interventions - of which Education Intervention (Tx1) is the first listed.

NCT02240134 reports a single indexed study location in Montana.

Frequently Asked Questions

What is clinical trial NCT02240134 about?

NCT02240134 is a clinical study titled "Wood Stove Interventions and Child Respiratory Health". Acute lower respiratory tract infections (LRTIs) account for more than 27% of all hospitalizations among US children under five years of age, with recurrent LRTIs in children a recognized risk factor for asthma. Residential biomass combustion leads to elevated indoor levels of fine particulate matte...

What is the current status of trial NCT02240134?

This trial is currently completed. It is a NA study. The enrollment target is 523 participants. The study started on 2014-11. Estimated completion is 2020-03.

What conditions does trial NCT02240134 study?

This clinical trial studies the following conditions: Lower Tract Respiratory Infection.

What interventions are being tested in trial NCT02240134?

The interventions under investigation include: Education Intervention (Tx1) (BEHAVIORAL), Air Filtration Unit Treatment (Tx2) (DEVICE), Placebo Intervention (Tx3) (DEVICE).

Who is sponsoring clinical trial NCT02240134?

This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02240134 being conducted?

This trial has 1 study location across Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT02240134's enrollment target sits among peer trials

523 189th of 2000 higher than 1,812 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03526835 · 523 participants · Phase 1

    A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

  • NCT04580134 · 524 participants · Phase 4

    CLOZAPINE Response in Biotype-1

  • NCT07158814 · 524 participants · Phase 4

    Safety of RSV Preventive Monoclonal Antibody

  • NCT06835686 · 522 participants · NA

    Collaborative Multi-level Obesity Intervention Engaging Underserved Communities Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02240134, the US trial registry maintained by the National Library of Medicine. NCT02240134 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.